Eye on FDA
A series focused on important FDA and related regulatory developments critical to the life sciences industry.
Filter by Category
Search Results
Eye on FDA
On February 1, 2026, the Food and Drug Administration (FDA) officially started accepting requests to participate in the FDA PreCheck pilot program. The goal of the program is to strengthen the domestic pharmaceutical supply chain by making the review and inspection process more predictable for U.S.-based drug manufacturing facilities.